Skip to main content

Identification and validation of plasma-based protein biomarkers for cediranib and olaparib in GY005, phase III

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

NRG Oncology

Start Date

August 1, 2020

End Date

December 31, 2024
 

Administered By

Medicine, Medical Oncology

Awarded By

NRG Oncology

Start Date

August 1, 2020

End Date

December 31, 2024